Diabetes News

Low income corresponded with a higher risk for death among individuals with type 2 diabetes, a South Korean-based cohort analysis published in JAMA Network Open suggested.

SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.

Sotagliflozin was not recommended for approval by the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee for glucose control as an adjunct to insulin in adults with type 1 diabetes and chronic kidney disease..

Time-restricted eating can improve the health of individuals with metabolic syndrome, who are on the precipice of type 2 diabetes, heart disease and other health complications, according to an expert.

SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported.

SAN ANTONIO — Dysregulated amino and fatty acid metabolism during late pregnancy was tied to elevated incidence of type 2 diabetes among women with a history of gestational diabetes, according to a presentation at ObesityWeek.

After decades of research, pharmacologic treatment of obesity gained significant traction with the launch of GLP-1 receptor agonists, and several potentially more potent drugs are currently in the pipeline, a speaker reported.

A decade after receiving gastric bypass or sleeve gastrectomy as adolescents, many people maintain their weight loss and achieve remission of obesity-related conditions, including diabetes, according to a study.

BOSTON — Behavioral modification with diet and exercise demonstrated similar weight-loss benefits vs. other pharmaceutical and surgical approaches to obesity management, but patients must remain adherent, a speaker reported.

ORLANDO — A pilot study found a hybrid online/in-person version of the Complete Health Improvement Program could be feasible for patients with type 2 diabetes, according to a poster presented at the Lifestyle Medicine Conference.